Question: In this study, Gukasyan et al. (2022) published a randomized controlled trial showing that depressive symptoms remained improved 12 months after receiving 2 doses of
In this study, Gukasyan et al. (2022) published a randomized controlled trial showing that depressive symptoms remained improved 12 months after receiving 2 doses of psilocybin along with psychotherapy. Would you consider this study statistically significant? Clinically significant? Why or why not
Step by Step Solution
There are 3 Steps involved in it
Get step-by-step solutions from verified subject matter experts
